JP2014505014A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014505014A5 JP2014505014A5 JP2013536845A JP2013536845A JP2014505014A5 JP 2014505014 A5 JP2014505014 A5 JP 2014505014A5 JP 2013536845 A JP2013536845 A JP 2013536845A JP 2013536845 A JP2013536845 A JP 2013536845A JP 2014505014 A5 JP2014505014 A5 JP 2014505014A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- amino acids
- amino acid
- acid sequence
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40740210P | 2010-10-27 | 2010-10-27 | |
| US61/407,402 | 2010-10-27 | ||
| US201161467894P | 2011-03-25 | 2011-03-25 | |
| US61/467,894 | 2011-03-25 | ||
| US201161502476P | 2011-06-29 | 2011-06-29 | |
| US61/502,476 | 2011-06-29 | ||
| PCT/US2011/058165 WO2012058480A1 (en) | 2010-10-27 | 2011-10-27 | Fviii peptides for immune tolerance induction and immunodiagnostics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016230723A Division JP2017095463A (ja) | 2010-10-27 | 2016-11-29 | 免疫寛容誘導および免疫診断のためのｆｖｉｉｉペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014505014A JP2014505014A (ja) | 2014-02-27 |
| JP2014505014A5 true JP2014505014A5 (https=) | 2014-12-11 |
| JP6122780B2 JP6122780B2 (ja) | 2017-04-26 |
Family
ID=45349271
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013536845A Expired - Fee Related JP6122780B2 (ja) | 2010-10-27 | 2011-10-27 | 免疫寛容誘導および免疫診断のためのｆｖｉｉｉペプチド |
| JP2016230723A Pending JP2017095463A (ja) | 2010-10-27 | 2016-11-29 | 免疫寛容誘導および免疫診断のためのｆｖｉｉｉペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016230723A Pending JP2017095463A (ja) | 2010-10-27 | 2016-11-29 | 免疫寛容誘導および免疫診断のためのｆｖｉｉｉペプチド |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US8969524B2 (https=) |
| EP (2) | EP3260132B1 (https=) |
| JP (2) | JP6122780B2 (https=) |
| KR (2) | KR102040867B1 (https=) |
| CN (2) | CN103298482B (https=) |
| AR (1) | AR083586A1 (https=) |
| AU (2) | AU2011319747C1 (https=) |
| BR (1) | BR112013010362A2 (https=) |
| CA (1) | CA2815239C (https=) |
| DK (1) | DK2632479T3 (https=) |
| EA (1) | EA034494B1 (https=) |
| ES (2) | ES2912455T3 (https=) |
| HK (1) | HK1215442A1 (https=) |
| MX (1) | MX347805B (https=) |
| NZ (2) | NZ703514A (https=) |
| PL (2) | PL2632479T3 (https=) |
| PT (1) | PT2632479T (https=) |
| SG (2) | SG189914A1 (https=) |
| TW (3) | TWI580430B (https=) |
| WO (1) | WO2012058480A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006063031A2 (en) | 2004-12-06 | 2006-06-15 | Haplomics | Allelic variants of human factor viii |
| RS56069B1 (sr) * | 2012-11-12 | 2017-10-31 | Apitope Int Nv | Faktor viii-izvedenih peptida za upotrebu u lečenju hemofilije a |
| EP2928303A4 (en) | 2012-12-07 | 2016-07-13 | Haplomics Inc | FACTOR VIII MUTATION REPAIR AND TOLERANCE INDUCTION |
| US20160038575A1 (en) * | 2013-03-15 | 2016-02-11 | Haplomics, Inc. | Compositions and methods for immune tolerance induction to factor viii replacement therapies in subjects with hemophilia a |
| CA2951150C (en) * | 2014-06-12 | 2024-05-28 | University Of Hawaii | Uses of humanized cobra venom factor for reducing or preventing immunogenicity |
| ES2869972T3 (es) * | 2015-01-26 | 2021-10-26 | Cellectis | Sistemas de receptores de antígenos quiméricos dirigidos por mAb para clasificar/agotar células inmunitarias genomanipuladas |
| KR102415992B1 (ko) | 2016-04-15 | 2022-07-04 | 다케다 야쿠힌 고교 가부시키가이샤 | 약물동역학 약물 투약 요법을 제공하는 방법 및 장치 |
| US10896749B2 (en) | 2017-01-27 | 2021-01-19 | Shire Human Genetic Therapies, Inc. | Drug monitoring tool |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005538694A (ja) * | 2002-04-18 | 2005-12-22 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 修飾されたｖｉｉｉ因子 |
| US7485314B2 (en) * | 2002-05-06 | 2009-02-03 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Induction of antigen specific immunologic tolerance |
| ATE427499T1 (de) * | 2004-05-21 | 2009-04-15 | Inst Systems Biology | Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen |
| US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
| EP3653699A1 (en) | 2006-01-04 | 2020-05-20 | Baxalta Incorporated | Oligopeptide-free cell culture media |
| GB0723712D0 (en) * | 2007-12-04 | 2008-01-16 | Apitope Technology Bristol Ltd | Peptides |
| US7673687B2 (en) | 2007-12-05 | 2010-03-09 | Halliburton Energy Services, Inc. | Cement compositions comprising crystalline organic materials and methods of using same |
| DE202007017320U1 (de) | 2007-12-07 | 2008-02-28 | Dittmann, Ludwig | Vorrichtung zur Raumbeduftung |
| GB0801513D0 (en) * | 2008-01-28 | 2008-03-05 | Circassia Ltd | Peptides from factor VIII |
| US20110081362A1 (en) | 2008-01-31 | 2011-04-07 | The Brigham And Women's Hospital, Inc. | Treatment of cancer |
| NZ593190A (en) | 2008-11-07 | 2013-01-25 | Baxter Int | Factor viii formulations |
-
2011
- 2011-10-27 BR BR112013010362A patent/BR112013010362A2/pt not_active Application Discontinuation
- 2011-10-27 ES ES17167928T patent/ES2912455T3/es active Active
- 2011-10-27 ES ES11796846.1T patent/ES2639039T3/es active Active
- 2011-10-27 DK DK11796846.1T patent/DK2632479T3/en active
- 2011-10-27 TW TW100139078A patent/TWI580430B/zh not_active IP Right Cessation
- 2011-10-27 NZ NZ703514A patent/NZ703514A/en unknown
- 2011-10-27 PL PL11796846T patent/PL2632479T3/pl unknown
- 2011-10-27 US US13/283,452 patent/US8969524B2/en active Active
- 2011-10-27 KR KR1020137013231A patent/KR102040867B1/ko active Active
- 2011-10-27 CA CA2815239A patent/CA2815239C/en active Active
- 2011-10-27 PT PT117968461T patent/PT2632479T/pt unknown
- 2011-10-27 AU AU2011319747A patent/AU2011319747C1/en active Active
- 2011-10-27 MX MX2013004753A patent/MX347805B/es active IP Right Grant
- 2011-10-27 TW TW106113613A patent/TW201730205A/zh unknown
- 2011-10-27 PL PL17167928.5T patent/PL3260132T3/pl unknown
- 2011-10-27 TW TW105138248A patent/TW201708251A/zh unknown
- 2011-10-27 EA EA201390617A patent/EA034494B1/ru not_active IP Right Cessation
- 2011-10-27 WO PCT/US2011/058165 patent/WO2012058480A1/en not_active Ceased
- 2011-10-27 CN CN201180063117.9A patent/CN103298482B/zh active Active
- 2011-10-27 NZ NZ609474A patent/NZ609474A/en unknown
- 2011-10-27 KR KR1020197032106A patent/KR102222864B1/ko not_active Expired - Fee Related
- 2011-10-27 JP JP2013536845A patent/JP6122780B2/ja not_active Expired - Fee Related
- 2011-10-27 EP EP17167928.5A patent/EP3260132B1/en active Active
- 2011-10-27 EP EP11796846.1A patent/EP2632479B1/en active Active
- 2011-10-27 SG SG2013028733A patent/SG189914A1/en unknown
- 2011-10-27 SG SG10201600656WA patent/SG10201600656WA/en unknown
- 2011-10-27 CN CN201510431485.4A patent/CN104926947A/zh active Pending
- 2011-10-28 AR ARP110103988A patent/AR083586A1/es not_active Application Discontinuation
-
2015
- 2015-01-23 US US14/604,622 patent/US9512198B2/en active Active
-
2016
- 2016-03-22 HK HK16103339.6A patent/HK1215442A1/zh unknown
- 2016-04-06 AU AU2016202155A patent/AU2016202155B2/en active Active
- 2016-11-02 US US15/341,936 patent/US20170267743A1/en not_active Abandoned
- 2016-11-29 JP JP2016230723A patent/JP2017095463A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014505014A5 (https=) | ||
| TWI880898B (zh) | 單鏈嵌合多肽及其用途 | |
| DK1773872T3 (en) | VARIABLE Lymphocyte Receptors, Associated Polypeptides and Nucleic Acids, and Uses thereof | |
| JP2010529860A5 (https=) | ||
| JP2017160222A5 (https=) | ||
| JP2021524270A5 (https=) | ||
| JP2021524275A5 (https=) | ||
| JP2017529067A5 (https=) | ||
| JP2017018125A5 (https=) | ||
| JP2013534812A5 (https=) | ||
| JP2016052315A5 (https=) | ||
| JP2016508143A5 (https=) | ||
| JP2013513377A5 (https=) | ||
| JP2006515749A5 (https=) | ||
| JP2013525305A5 (https=) | ||
| JP2013521789A5 (https=) | ||
| JP2013517783A5 (https=) | ||
| JP2010533200A5 (https=) | ||
| JP2018518956A5 (https=) | ||
| JP2014521313A5 (https=) | ||
| US20230197192A1 (en) | Selecting neoantigens for personalized cancer vaccine | |
| JP2015509707A5 (https=) | ||
| JP2015514132A5 (https=) | ||
| JP2019520038A5 (https=) | ||
| JP2015529629A5 (https=) |